DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Didier Argentin

Business Development Sr Director, Europe

Quantoom Biosciences

Nivelles, Belgium

8 profile visitsCompanies/Industry

Since 2021, I am the head of BD Europe of Quantoom Biosciences, where I acquired a strong expertise in the field of m/saRNA manufacturing processes & nanoparticles.

My organisation

About me

25 years expertise in leading the business development of bioproduction companies :

@ Former CBO of Henogen/Novasep CDMO ( currently the Belgian manufacturing site of Thermo-Fischer, for viral vectors) : 2002-2011

@ Didier has also been the former CBO, cofounder and board member of MasTherCell, CDMO for cell therapeutics (acquired by Catalent in Feb 2020 for $315M) : 2011-2014

@ as well as the founder and CEO of SynAbs : CRDO for monoclonal antibodies for the IVD market : 2014-2020

@ Since 2021, He is the current head of BD Europe of Quantoom Biosciences, where he acquired a very strong expertise in the field of mRNA and saRNA manufacturing processes, nanoparticles and analyticals; Didier also participated in 2023 to the implementation and starting mRNA operations and business at ExoThera CDMO, as well as Samabriva 3M€ funding as board member.

Social media

Additional questions

Interests

VaccinesPharmaceutical / TherapeuticsLivestockEnabling technology (assay, delivery, formulation, manufacturing, ...)Companion animals

What is your primary goal for attending this event?

Networking with industry professionalsExploring potential collaborationsShowcasing products or solutions